Hannoversche Kinderheilanstalt — Clinical Trial Site

13 Registered trials

9 Currently recruiting

Organisation

Hannoversche Kinderheilanstalt

Location

Hanover, Germany

Identifier

ORG-100029160

Address

Janusz-Korczak-Allee 12, Bult, 30173, Germany

Departments

3152 : Diabetologie, Endokrinologie, Gastroenterologie und Klinische Forschung
Dermatology
Diabetes Center
Diabeteszentrum für Kinder und Jugendliche
Diabetology, endocrinology, gastroenteology and clinical research
Division of Pediatric Diabetology/Endocrinology/Gastroenterology and Clinical Research
Hannoversche Kinderheilanstalt Allg. Pädiatrie/Klin. Forschung
Kinder- und Jugendkrankenhaus Auf der Bult
Kinder- und Jugendkrankenhaus AUF DER BULT, Diabetes- und Endokrinologiezentrum
NA
Paediatric Endocrinology & Diabetology

Clinical trials at this site (13)

Search interface

A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRES… Recruiting

2025-522170-36-00 Diabetes Mellitus, Type 1 5 2026-02-03
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults (BARICADE-DELAY) Recruiting

2025-521797-34-00 Diabetes Mellitus, Type 1 5 2026-01-20
Phase III clinical trial of ABCB5+ MSCs for the treatment of EB Recruiting

2022-500266-10-00 Recessive Dystrophic Epidermolysis Bullosa(RDEB) and Ju 5 2023-06-13
SAFEGUARD (SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes) Study Recruiting

2025-521560-36-00 Type 1 Diabetes 4 2026-04-22
A Phase 3 Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children with Short Statur… Recruiting

2025-523079-44-00 Turner Syndrome (TS) 5 2026-04-15
A study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with Stage 3 Type 1 Diab… Recruiting

2024-519494-19-00 Nutritional and metabolic diseases 5 2025-12-22
Study to evaluate efficacy and safety of inclisiran in children aged 6 to under 12 years of age with heterozygous familial hypercholesterole… Recruiting

2024-514594-21-00 Heterozygous Familial Hypercholesterolemia 5 2025-03-13
Anti-viral action against Type 1 diabetes autoimmunity GPPAD-05-AVAnT1A Recruiting

2023-507348-35-00 Risk for Type 1 Diabetes 6 2024-05-30
Frexalimab in preservation of endogenous insulin secretion compared to placebo in adults, adolescents and children on top of Insulin therapy… Recruiting

2022-500531-36-00 Type 1 diabetes mellitus 4 2024-02-02
STEP TEENS Weight Maintenance: A research study on how well semaglutide helps teenagers with excess body weight to lose weight and maintain … Ended

2023-508055-40-00 Obesity 6 2025-02-18
An open-label extension multi-centre trial in adult subjects diagnosed with Type 1 diabetes mellitus exploring the effect of long-term Verap… Ended

2024-515234-33-00 Type 1 diabetes mellitus (T1D) 4 2024-11-21
STEP Young: A research study on how well semaglutide helps children and teenagers with excess body weight lose weight Ended

2022-502922-41-00 Obesity and overweight 5 2023-07-03
A randomised, double-blind, placebo controlled, parallel group, multi-centre trial in adult subjects with newly diagnosed type 1 diabetes me… Ended

2023-506545-27-01 Diabetes mellitus, Type 1 4 2025-01-28